Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes: Assessment of Detemir Administration in a Progressive Treat-To-Target Trial (ADAPT)

OBJECTIVE—The purpose of this study was to compare effects of insulin detemir once daily versus twice a day in a basal-bolus insulin regimen. RESEARCH DESIGN AND METHODS—In this open-label, 7-month study, 520 patients with type 1 diabetes were randomly assigned to receive detemir once daily or twice...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Floch, Jean-Pierre, Lévy, Marc, Mosnier-Pudar, Helen, Nobels, Frank, Laroche, Sylvie, Gonbert, Sophie, Eschwege, Eveline, Fontaine, Pierre
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606825/
https://www.ncbi.nlm.nih.gov/pubmed/18945928
http://dx.doi.org/10.2337/dc08-0332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606825/
https://www.ncbi.nlm.nih.gov/pubmed/18945928
http://dx.doi.org/10.2337/dc08-0332

Ejemplares similares